Description
Chemical name: 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
Formula: C17H19N5
Antreol is a medication that is used to treat breast cancer in women who have gone through menopause. It is classified as a non-steroidal aromatase inhibitor, which means that it works by blocking the production of estrogen in the body. The active half-life of Antreol is approximately 2 days, meaning that the medication stays active in the body for a short period of time after it has been taken.
The typical dosage of Antreol is 0.5 to 1 mg per day, depending on the individual patient’s needs and medical condition. Unlike some other medications used in breast cancer treatment, Antreol is not known to cause acne or water retention. It is also not associated with hepatotoxicity, or liver damage. Antreol does not cause HBR, or hot flashes, breast tenderness, and mood swings.
The active substance in Antreol is anastrozole, which is a potent aromatase inhibitor that works by blocking the production of estrogen in the body. By blocking estrogen production, Antreol helps to slow or stop the growth and spread of breast cancer cells in postmenopausal women.
Antreol is available in the form of 10 pills x 1 mg and is manufactured by Knoll Healthcare, a reputable pharmaceutical company. In conclusion, Antreol is a highly effective medication that is used to treat breast cancer in postmenopausal women. It is associated with few side effects and is considered a safe and effective option for most patients.
Reviews
There are no reviews yet.